Strategies for the Design of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Lessons from the Development of Seven Representative Paradigms

被引:119
作者
Li, Dongyue [1 ]
Zhan, Peng [1 ]
De Clercq, Erik [2 ]
Liu, Xinyong [1 ]
机构
[1] Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Jinan 250012, Shandong, Peoples R China
[2] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
基金
高等学校博士学科点专项科研基金; 中国博士后科学基金; 中国国家自然科学基金;
关键词
RESISTANT MUTANT VIRUSES; MEDICINAL CHEMISTRY; DRUG CANDIDATES; MOLECULAR HYBRIDIZATION; ANGSTROM RESOLUTION; ANTIVIRAL ACTIVITY; ETRAVIRINE TMC125; BROAD POTENCY; DAPY ANALOGS; WILD-TYPE;
D O I
10.1021/jm200990c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:3595 / 3613
页数:19
相关论文
共 80 条
[1]   Halogen bonds in biological molecules [J].
Auffinger, P ;
Hays, FA ;
Westhof, E ;
Ho, PS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (48) :16789-16794
[2]  
BONNEAU PR, 2004, 11 C RETR OPP INF SA
[3]  
Brotherton-Pleiss CE, 2008, [No title captured], Patent No. [WO 2008071587, 2008071587]
[4]   On scaffolds and hopping in medicinal chemistry [J].
Brown, Nathan ;
Jacoby, Edgar .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (11) :1217-1229
[5]   Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1 [J].
Chan, JH ;
Freeman, GA ;
Tidwell, JH ;
Romines, KR ;
Schaller, LT ;
Cowan, JR ;
Gonzales, SS ;
Lowell, GS ;
Andrews, CW ;
Reynolds, DJ ;
St Clair, M ;
Hazen, RJ ;
Ferris, RG ;
Creech, KL ;
Roberts, GB ;
Short, SA ;
Weaver, K ;
Koszalka, GW ;
Boone, LR .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (05) :1175-1182
[6]   New uses for old drugs [J].
Chong, Curtis R. ;
Sullivan, David J., Jr. .
NATURE, 2007, 448 (7154) :645-646
[7]   Recent developments in fragment-based drug discovery [J].
Congreve, Miles ;
Chessari, Gianni ;
Tisi, Dominic ;
Woodhead, Andrew J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) :3661-3680
[8]   Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants [J].
Das, K ;
Clark, AD ;
Lewi, PJ ;
Heeres, J ;
de Jonge, MR ;
Koymans, LMH ;
Vinkers, HM ;
Daeyaert, F ;
Ludovici, DW ;
Kukla, MJ ;
De Corte, B ;
Kavash, RW ;
Ho, CY ;
Ye, H ;
Lichtenstein, MA ;
Andries, K ;
Pauwels, R ;
de Béthune, MP ;
Boyer, PL ;
Clark, P ;
Hughes, SH ;
Janssen, PAJ ;
Arnold, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) :2550-2560
[9]   From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125):: Fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase [J].
De Corte, BL .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) :1689-1696
[10]   Tri-substituted triazoles as potent non-nucleoside inhibitors of the HIV-1 reverse transcriptase [J].
De La Rosa, Martha ;
Kim, Hong Woo ;
Gunic, Esmir ;
Jenket, Cheryl ;
Boyle, Uyen ;
Koh, Yung-hyo ;
Korboukh, Ilia ;
Allan, Matthew ;
Zhang, Weijian ;
Chen, Huanming ;
Xu, Wen ;
Nilar, Shahul ;
Yao, Nanhua ;
Hamatake, Robert ;
Lang, Stanley A. ;
Hong, Zhi ;
Zhang, Zhijun ;
Girardet, Jean-Luc .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (17) :4444-4449